Imuno is pioneering the power of machine learning to build a structure-based discovery engine to identify cancer-specific epitopes that can be exploited by novel therapeutic strategies. Our discovery engine not only identifies epitopes that are 100% unique to a patient's tumor, it selects those have the best properties for therapeutic targeting.